Abstract
A prospective study of prognostic factors for patients with non-Hodgkin's lymphoma was carried out based on the Kiel histopathological classification. Other presentation features assessed for prognostic value included clinical features, haematological and biochemical findings, and immunochemical findings. The most powerful factors that emerged were the presence or absence of systemic symptoms and the histopathological grade of malignancy of the lymphoma (whether low or high grade). These 2 factors were largely independent. Clinical Stage I disease also carried a good prognosis, but beyond this, staging gave little further prognostic information. Nine of the group of 15 patients with Stage I high grade lymphoma have achieved prolonged disease-free survival after local therapy only. After allowing for histopathology and symptom assessment in patients with Stage II-IV disease, other factors, with the exception of C-reactive protein levels, were of minor importance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Leonard, R., Cuzick, J., MacLennan, I. et al. Prognostic factors in non-Hodgkin's lymphoma: The importance of symptomatic stage as an adjunct to the Kiel histopathological classification. Br J Cancer 47, 91–102 (1983). https://doi.org/10.1038/bjc.1983.11
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.11
This article is cited by
-
Long-term outcome of follicular low-grade lymphoma a report of 91 patients
Annals of Hematology (1993)
-
Bedeutung klinischer und laborchemischer Parameter für Verlauf und Prognose der Non-Hodgkin-Lymphome
Klinische Wochenschrift (1986)